All Stories

  1. Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory Deficits
  2. Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse
  3. Discovery of Pitolisant, the First Marketed Histamine H3 -Receptor Inverse Agonist/Antagonist for Treating Narcolepsy*
  4. The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages
  5. HPV Vaccination: Prevention of Cervical Cancer in Serbia and in Europe
  6. From Magic Bullet To Magic Pump Gun: Multi-targeting Drugs For Neurodegenerative Diseases
  7. Another Piece Of Puzzle In Adjuvant Treatment Of Inflammatory Diseases With Natural Compounds
  8. Low Field NMR Determination of pKa Values for Hydrophilic Drugs for Students in Medicinal Chemistry
  9. Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands
  10. Further Developments
  11. Meet Our Editorial Board Member
  12. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
  13. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats
  14. Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
  15. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases
  16. Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism
  17. Cherry-picked ligands at histamine receptor subtypes
  18. Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylation
  19. Histamine H4 Receptor Antagonists: A New Approach for Tinnitus Treatment?
  20. Next Steps in Advancing Publication
  21. Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors
  22. Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands
  23. Psychostimulants
  24. Anticonvulsive effect of nonimidazole histamine H3 receptor antagonists
  25. Procognitive Properties of Drugs with Single and Multitargeting H3Receptor Antagonist Activities
  26. Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283
  27. Synthesis of novel dansyl-labeled Celecoxib derivatives
  28. Scaffold variations in amine warhead of histamine H3 receptor antagonists
  29. Polymorphisms and genetic linkage of histamine receptors
  30. Histamine H4 Receptor: A Novel Drug Target in Immunoregulation and Inflammation
  31. Bodilisant—A Novel Fluorescent, Highly Affine Histamine H3 Receptor Ligand
  32. Histamine receptor subtypes a century of rational drug design
  33. Novel Chalcone-Based Fluorescent Human Histamine H3 Receptor Ligands as Pharmacological Tools
  34. Synthesis of 1,2,3-Triazole Elements in Histamine H3 Receptor Ligands
  35. Efficient chromatography-free synthesis of the oxy-analogue of fingolimod
  36. ChemInform Abstract: Dopamine D3 Receptor Ligands with Antagonist Properties
  37. Kojic Acid Derivatives as Histamine H3 Receptor Ligands
  38. Histamine H3 Receptors Are Involved in the Protective Effect of Ghrelin against HCl-Induced Gastric Damage in Rats
  39. Histamine H3and H4receptors as novel drug targets
  40. Histamine H4receptor antagonism reduces hapten-induced scratching behaviour but not inflammation
  41. Drug Discovery
  42. Antitussiva und Expektorantien. Medizinisch-chemische Aspekte
  43. Histamine H3- Receptor Agonists and Antagonists
  44. W1955 Resveratrol Analogues with Potent Anticarcinogenic Properties
  45. Histamine H3 Receptor Antagonists Go to Clinics
  46. Designs that Enrich Lives: Archiv der Pharmazie 10/2007
  47. Highly Potent Fluorescence-Tagged Nonimidazole Histamine H3 Receptor Ligands
  48. Medizinische Chemie von Histamin-H2-Rezeptorantagonisten: Klassische Wirkstoffentwicklung
  49. Neuroprotektives B2 verstärkt die Ablagerung fehlgefalteter Proteine bei C. Huntington und M. Parkinson
  50. Predicting Compound Selectivity by Self-Organizing Maps: Cross-Activities of Metabotropic Glutamate Receptor Antagonists
  51. Editorial: Impact and other Improvements
  52. From Target to Lead Synthesis
  53. Kaffee gegen Morbus Parkinson?
  54. Retinazellen gegen Morbus Parkinson
  55. Editorial: Pharmazie in unserer Zeit 3/2006
  56. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities
  57. Komplexe Regulationen bei Dopamin-D2-Rezeptoren
  58. Neurotransmitters, Agonists, and Antagonists
  59. Medizinische Chemie der L-Typ-Calcium-Kanalblocker: Dihydropyridine und Nicht-Dihydropyridine
  60. Frontiers in GPCR Research
  61. Protonenpumpeninhibitoren: Strukturen, Mechanismen und Entwicklungen
  62. Neue Wirkstoffe zur GERD-Behandlung: Innovationen in der Pipeline
  63. From Virtual to Real Screening for D3 Dopamine Receptor Ligands
  64. A New Face for Archiv der Pharmazie
  65. Dedication to H. Schönenberger and Thanks to R. Hartmann
  66. Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists
  67. Hemmstoffe von Beta-Adrenozeptoren: Gemeinsamkeiten und Unterschiede
  68. Turning from monogamy to strategic promiscuity
  69. Wiederaufnahme-Hemmung an der Präsynapse als Wirkprinzip: Medizinische Chemie moderner Antidepressiva— Targets und Arzneistoffe
  70. H1-Histamines: Development, Structure and Novel Trends
  71. H1-Antihistaminika: Entwicklungen, Strukturen und neue Tendenzen
  72. Medizinisch-chemische Aspekte von Statinen: Wirkmechanismus von HMG-CoA-Reduktase-Inhibitoren
  73. Recent advances in histamine H3/H4receptor ligands
  74. Book Review: Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects, By Oliver von Bohlen und Halbach and Rolf Dermitzel
  75. Neues zum alten Histamin II. Ionenkanäle inDrosophila
  76. Neues zum alten Histamin I. Ein weiteres Mitglied in der Rezeptorfamilie
  77. Recent advances in histamine H3/H4 receptor ligands
  78. Dopamine D3 Receptor Ligands with Antagonist Properties
  79. Identification of the dopamine autoreceptor in the guinea-pig retina as D2receptor using novel subtype-selective antagonists
  80. Separation of chiral 4‐substituted imidazole derivatives by cyclodextrin‐modified capillary electrophoresis
  81. 6 The Histamine H3 Receptor and its Ligands
  82. Separation of chiral 4-substituted imidazole derivatives by cyclodextrin-modified capillary electrophoresis
  83. ChemInform Abstract: Convenient Procedures for Synthesis of Ciproxifan, a Histamine H3-Receptor Antagonist.
  84. Convenient Procedures for Synthesis of Ciproxifan, a Histamine H3-Receptor Antagonist
  85. Teil 2: Therapiekonzepte und neue Rezeptorliganden
  86. Struktur, Funktion und potentielle therapeutische Bedeutung von NMDA-Rezeptoren
  87. Histamine H3-receptor antagonists inhibit gastroprotection by (R)-α-methylhistamine in the rat
  88. Iododestannylation: an improved synthesis of [125I]iodoproxyfan, a specific radioligand of the histamine H3 receptor
  89. Binding of histamine H3-receptor antagonists to hematopoietic progenitor cells
  90. Computer-Assisted Analysis of Histamine H2− and H3-Receptor Agonists
  91. Azines and Diazines as Potential Histamine H3-Receptor Antagonists
  92. Design of histamine H3-receptor agonists and antagonists